Gabapentin-01 (Gabapentin 01)
Chemical structure diagram of gabapentin showing a cyclohexane ring with attached amino and carboxyl groups.*
Gabapentin
Product Images NDC 59063-127
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 59063-127). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Kiel Laboratories, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Gabapentin-02 (Gabapentin 02)
A line graph showing the mean pain score over 8 weeks comparing placebo and Gabapentin 2600 mg/day. The graph is divided into a 4-week dose titration period followed by a 4-week fixed dose period, with Gabapentin showing a greater reduction in mean pain score compared to placebo throughout the 8 weeks.*
Gabapentin-03 (Gabapentin 03)
A line graph showing mean pain scores over a 7-week period for three groups: placebo, Gabapentin 1600 mg/day, and Gabapentin 2400 mg/day. The x-axis represents weeks from baseline to 7, including a 3-week dose titration period and a 4-week fixed dose period. The y-axis shows mean pain scores ranging from 0 to 10. Both Gabapentin groups demonstrate a decrease in pain scores compared to placebo, with statistical significance noted (p < 0.01).*
Gabapentin-04 (Gabapentin 04)
A bar graph displaying the percentage of responders at the endpoint for two different studies comparing placebo (PBO) and Gabapentin (GBP) at various doses (1800, 2400, 3600). The vertical axis shows percentage values from 0 to 50%, highlighting significant differences between placebo and Gabapentin treatments in these studies.*
Gabapentin-05 (Gabapentin 05)
A scatter plot comparing three studies (a, b, and c) showing the percentage difference on the y-axis versus daily gabapentin dose in mg on the x-axis, with dose values ranging from 600 mg to 1800 mg.*
Gabapentin-06 (Gabapentin 06)
Gabapentin Oral Solution 250 mg/5 mL label from Kiel Laboratories, Inc. The label indicates a 470 mL bottle, with dispensing instructions and storage conditions. It includes a lot number, expiration date section, barcode, and manufacturing details. The solution strength and volume are prominently displayed.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
